BGLC·090628306·US·equity·Basic Materials - Specialty Chemicals
BGLC (BIONEXUS GENE LAB CORP) is held by 2 institutional investors as of Q1 2026. Largest holders: UBS Group AG ($495), WELLS FARGO & COMPANY/MN ($2). Net institutional sentiment: Bullish.
See how BGLC's score breaks down across 4 SEC sources
No recent insider, activist, or congressional trades found for this stock
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer